Cellebrite DI Ltd.
corporate_fare Company Profile
Cellebrite DI Ltd. (NASDAQ:CLBT) is a publicly traded company in the Technology sector. Wiseek has independently scored 8 items for CLBT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-14, rated 7/10. Across its 8 most recent items scored 7 or higher, the top rating is 8/10, with 3 rated 8 or above. Recent SEC coverage for CLBT spans 6-K.
Recent high-impact activity:
- Securities Investigation Launched Into Cellebrite's Guidance Cut
- Cellebrite Plunges 31% to 52-Week Low After Slashing FY26 Guidance
- Cellebrite Appoints Shiven Ramji as CEO and Lowers FY26 ARR and Revenue Outlook
- Cellebrite Posts Q2 EPS of 2 Cents, Beating Expectations
- Cellebrite Reports Strong Q1 2026 Results with 19% Revenue Growth and Positive Outlook
Financial Snapshot
Short Interest & Short Volume
3.49 days to coverFINRA reported short interest of 9,467,334 shares in CLBT as of the September 15, 2026 settlement, a 14.1% increase from the prior period — about 3.5 days to cover at its recent average daily volume. On October 2, 2026, 39.6% of CLBT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
CLBT files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.